glp-1 mitochondria Receptor Agonist Improves Mitochondrial Energy Status and Attenuates Nephrotoxicity In Vivo and In Vitro Glucagon-like peptide-1 receptor: mechanisms and

Understanding your genetic predispositions in GLP-1R, GIPR, and metabolic pathways can support a personalized discussion with your healthcare provider about which receptor-targeting strategytriple-agonist, dual-agonist, or monoagonistmay be most appropriate for your metabolic profile, weight management goals, and risk tolerance

Wootten D, Miller LJ, Koole C, et al

The myriad of effects of endogenous glucagon-like peptide-1 (GLP-1) make it an attractive target for diabetes therapy

Evaluation of the therapeutic effects of mycophenolate mofetil targeting Nrf-2 and NLRP3 inflammasome in acetic acid induced ulcerative colitis in rats

Evid Based Complement Alternat Med

In the course of his cloning of the receptor Thorens happened to attend a small conference in Monaco organised by the Juvenile Diabetes Research Foundation